-
Something wrong with this record ?
Validity of mesothelin in occupational medicine practice
P. Smolková, M. Nakládalová, J. Zapletalová, P. Jakubec, H. Vildová, V. Kolek, M. Petřek, Z. Nakládal,
Language English Country Poland
Document type Journal Article, Research Support, Non-U.S. Gov't, Validation Study
Grant support
NT13569
MZ0
CEP Register
Digital library NLK
Full text - Article
Source
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2001
ProQuest Central
from 2006-01-01
Open Access Digital Library
from 2011-01-01
Medline Complete (EBSCOhost)
from 2002-01-01
Health & Medicine (ProQuest)
from 2006-01-01
Psychology Database (ProQuest)
from 2006-01-01
Public Health Database (ProQuest)
from 2006-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2006
- MeSH
- Asbestos toxicity MeSH
- GPI-Linked Proteins blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Longitudinal Studies MeSH
- Mesothelioma blood diagnosis etiology MeSH
- Biomarkers, Tumor blood MeSH
- Occupational Exposure adverse effects MeSH
- Occupational Medicine methods MeSH
- Predictive Value of Tests MeSH
- Prospective Studies MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Validation Study MeSH
OBJECTIVES: Malignant mesothelioma (MM) is the most serious asbestos-related disease. Its increasing incidence is alarming, suggesting the need for as early diagnosis as possible. This 4.5-year prospective longitudinal study aimed at assessing the benefit of measuring serum mesothelin as a marker for diagnosing malignant mesothelioma in individuals with previous occupational exposure to asbestos, as a part of their clinical follow-up care. MATERIAL AND METHODS: The study comprised 309 participants (235 males, 74 females) with a mean age of 58.9 years (standard deviation (SD) = 9.8) and a mean duration of exposure to asbestos dust of 13.4 years (SD = 9.3). From 2009 to June 2013, all subjects were followed at a department of occupational medicine in Olomouc. Apart from the standard parts of medical examination (history, physical examination, simple chest radiographs and spirometry), the patients' serum mesothelin levels were determined by the Mesomark immunoenzymatic diagnostic assay. Statistical analysis of the validity of serum mesothelin level measurement was carried out with respect to the diagnosis of MM. RESULTS: Among the participants, 16 (5.2%) individuals (14 males and 2 females) were diagnosed with malignant mesothelioma. Based on the detected mesothelin levels, their validity for prediction of malignant mesothelioma was calculated as follows: sensitivity - 0.75, specificity - 0.962, positive predictive value - 0.706, negative predictive value - 0.969, positive and negative likelihood ratios - 19.95 and 0.26, respectively, and diagnostic odds ratio - 76.8, at a 95% confidence interval. CONCLUSIONS: The high specificity was identified indicating the low false positivity as well. In the case of detecting elevated soluble mesothelin-related peptides (SMRP) levels in formerly asbestos-exposed individuals, the possibility of the presence of MM should be included into the clinical consideration. The high negative predictive value denotes a lower probability of the presence of MM in patients with normal SMRP levels but due to the limiting lower sensitivity this possibility cannot be entirely excluded.
Palacký University Olomouc Czech Republic
Regional Public Health Authority of the Olomouc Region Olomouc Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc17014020
- 003
- CZ-PrNML
- 005
- 20191025111653.0
- 007
- ta
- 008
- 170413s2016 pl f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.13075/ijomeh.1896.00637 $2 doi
- 035 __
- $a (PubMed)26988879
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a pl
- 100 1_
- $a Smolková, Petra $u Palacký University, Olomouc, Czech Republic (Faculty of Medicine and Dentistry and University Hospital Olomouc, Department of Occupational Medicine). smolkova.p@gmail.com. $7 _AN064305
- 245 10
- $a Validity of mesothelin in occupational medicine practice / $c P. Smolková, M. Nakládalová, J. Zapletalová, P. Jakubec, H. Vildová, V. Kolek, M. Petřek, Z. Nakládal,
- 520 9_
- $a OBJECTIVES: Malignant mesothelioma (MM) is the most serious asbestos-related disease. Its increasing incidence is alarming, suggesting the need for as early diagnosis as possible. This 4.5-year prospective longitudinal study aimed at assessing the benefit of measuring serum mesothelin as a marker for diagnosing malignant mesothelioma in individuals with previous occupational exposure to asbestos, as a part of their clinical follow-up care. MATERIAL AND METHODS: The study comprised 309 participants (235 males, 74 females) with a mean age of 58.9 years (standard deviation (SD) = 9.8) and a mean duration of exposure to asbestos dust of 13.4 years (SD = 9.3). From 2009 to June 2013, all subjects were followed at a department of occupational medicine in Olomouc. Apart from the standard parts of medical examination (history, physical examination, simple chest radiographs and spirometry), the patients' serum mesothelin levels were determined by the Mesomark immunoenzymatic diagnostic assay. Statistical analysis of the validity of serum mesothelin level measurement was carried out with respect to the diagnosis of MM. RESULTS: Among the participants, 16 (5.2%) individuals (14 males and 2 females) were diagnosed with malignant mesothelioma. Based on the detected mesothelin levels, their validity for prediction of malignant mesothelioma was calculated as follows: sensitivity - 0.75, specificity - 0.962, positive predictive value - 0.706, negative predictive value - 0.969, positive and negative likelihood ratios - 19.95 and 0.26, respectively, and diagnostic odds ratio - 76.8, at a 95% confidence interval. CONCLUSIONS: The high specificity was identified indicating the low false positivity as well. In the case of detecting elevated soluble mesothelin-related peptides (SMRP) levels in formerly asbestos-exposed individuals, the possibility of the presence of MM should be included into the clinical consideration. The high negative predictive value denotes a lower probability of the presence of MM in patients with normal SMRP levels but due to the limiting lower sensitivity this possibility cannot be entirely excluded.
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a azbest $x toxicita $7 D001194
- 650 _2
- $a nádorové biomarkery $x krev $7 D014408
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a GPI-vázané proteiny $x krev $7 D058851
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a longitudinální studie $7 D008137
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mezoteliom $x krev $x diagnóza $x etiologie $7 D008654
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a pracovní expozice $x škodlivé účinky $7 D016273
- 650 _2
- $a pracovní lékařství $x metody $7 D009787
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a prospektivní studie $7 D011446
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a validační studie $7 D023361
- 700 1_
- $a Nakládalová, Marie $u Palacký University, Olomouc, Czech Republic (Faculty of Medicine and Dentistry and University Hospital Olomouc, Department of Occupational Medicine). $7 stk2008428573
- 700 1_
- $a Zapletalová, Jana $u Palacký University, Olomouc, Czech Republic (Faculty of Medicine and Dentistry, Department of Medical Biophysics). $7 xx0111614
- 700 1_
- $a Jakubec, Petr, $u Palacký University, Olomouc, Czech Republic (Faculty of Medicine and Dentistry and University Hospital Olomouc, Department of Respiratory Medicine). $d 1971- $7 mzk2007381840
- 700 1_
- $a Vildová, Helena $u Palacký University, Olomouc, Czech Republic (Faculty of Medicine and Dentistry and University Hospital Olomouc, Department of Occupational Medicine). $7 xx0106811
- 700 1_
- $a Kolek, Vítězslav, $u Palacký University, Olomouc, Czech Republic (Faculty of Medicine and Dentistry and University Hospital Olomouc, Department of Respiratory Medicine). $d 1953-2020 $7 jn20000401390
- 700 1_
- $a Petřek, Martin, $u Palacký University, Olomouc, Czech Republic (Faculty of Medicine and Dentistry, Department of Pathological Physiology). $d 1963- $7 jn20000401972
- 700 1_
- $a Nakládal, Zdeněk $u Regional Public Health Authority of the Olomouc Region, Olomouc, Czech Republic. $7 xx0105442
- 773 0_
- $w MED00007261 $t International journal of occupational medicine and environmental health $x 1896-494X $g Roč. 29, č. 3 (2016), s. 395-404
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26988879 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20170413 $b ABA008
- 991 __
- $a 20191025112129 $b ABA008
- 999 __
- $a ok $b bmc $g 1200485 $s 974798
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 29 $c 3 $d 395-404 $i 1896-494X $m International journal of occupational medicine and environmental health $n Int J Occup Med Environ Health $x MED00007261
- GRA __
- $a NT13569 $p MZ0
- LZP __
- $a Pubmed-20170413